211 related articles for article (PubMed ID: 22343008)
1. Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study.
Wang CC; Chen PS; Hsu CW; Wu SJ; Lin CT; Gean PW
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):111-20. PubMed ID: 22343008
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity.
Cho KS; Kwon KJ; Choi CS; Jeon SJ; Kim KC; Park JH; Ko HM; Lee SH; Cheong JH; Ryu JH; Han SH; Shin CY
Glia; 2013 May; 61(5):694-709. PubMed ID: 23378038
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
[TBL] [Abstract][Full Text] [Related]
4. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes.
Wang C; Luan Z; Yang Y; Wang Z; Cui Y; Gu G
Neurosci Lett; 2011 Jun; 497(2):122-7. PubMed ID: 21543053
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-derived estrogen enhances synapse formation and synaptic transmission between cultured neonatal rat cortical neurons.
Hu R; Cai WQ; Wu XG; Yang Z
Neuroscience; 2007 Feb; 144(4):1229-40. PubMed ID: 17184929
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid-exposed astrocytes impair inhibitory synapse formation and function.
Takeda K; Watanabe T; Oyabu K; Tsukamoto S; Oba Y; Nakano T; Kubota K; Katsurabayashi S; Iwasaki K
Sci Rep; 2021 Jan; 11(1):23. PubMed ID: 33420078
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons.
Kumamaru E; Egashira Y; Takenaka R; Takamori S
Neurosci Lett; 2014 May; 569():142-7. PubMed ID: 24708928
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium valproate on synaptic transmission and neuronal excitability in rat hippocampus.
Yong W; Zhang MM; Wang S; Ruan DY
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1062-7. PubMed ID: 19413604
[TBL] [Abstract][Full Text] [Related]
10. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
[TBL] [Abstract][Full Text] [Related]
13. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
14. Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons.
Martín ED; Pozo MA
Neuropharmacology; 2004 Mar; 46(4):555-61. PubMed ID: 14975679
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations.
Nishino S; Ohtomo K; Numata Y; Sato T; Nakahata N; Kurita M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):17-22. PubMed ID: 21803112
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
17. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
18. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
19. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
[TBL] [Abstract][Full Text] [Related]
20. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
